How FGC-Linked Inflows and Retail Trading Momentum At XP (XP) Has Changed Its Investment Story

• On March 16, 2026, at its Global Conference, XP Inc. drew attention as analysts highlighted a stronger-than-expected start to the year driven by heavier retail equity trading and anticipated client reimbursements from Brazil’s deposit insurance fund (FGC) flowing back into XP’s platform.
• The interesting angle for investors is how these FGC-related inflows, if reinvested into fixed-income products, could generate upfront commissions that temporarily enhance XP’s revenue mix and fee visibility.
• We’ll now examine how this potential boost from reinvested FGC reimbursements may influence XP’s broader investment narrative and outlook.

We've uncovered the 12 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

XP Investment Narrative Recap

To own XP today, you need to believe in its role as a leading, scalable investment platform in Brazil, with earnings tied closely to client activity and asset flows. The Global Conference update about stronger early 2026 trading and FGC reimbursements may support the key near term catalyst: healthier retail engagement and fee generation. However, it does little to resolve the main risk around competitive pressure and potentially lower take rates as advisory and fee based models expand.

Among recent announcements, the Q4 2025 and full year 2025 results stand out in this context, with revenue of R$4,938 million in Q4 and R$18,398.6 million for the year, alongside net income of R$1,282 million and R$5,169.79 million respectively. These figures provide the base from which any FGC related inflow boost in early 2026 would be measured, helping investors gauge whether higher trading volumes and upfront commissions are improving XP’s earnings quality or just timing.

Yet, against this backdrop of stronger retail flows, investors should still be aware of the risk that...

Read the full narrative on XP (it's free!)

XP's narrative projects R$26.2 billion revenue and R$7.2 billion earnings by 2029. This requires 13.8% yearly revenue growth and about a R$2.0 billion earnings increase from R$5.2 billion today.

Uncover how XP's forecasts yield a $24.11 fair value, a 36% upside to its current price.

Exploring Other Perspectives

The most optimistic analysts were already assuming XP could reach about R$26.6 billion in revenue and R$7.3 billion in earnings, but if FGC driven fixed income flows keep accelerating while clients slowly shift toward lower fee models, the gap between that upbeat view and more cautious expectations could widen further, so it is worth comparing how differently you and those bullish forecasts frame XP’s long term margin resilience.

Explore 5 other fair value estimates on XP - why the stock might be worth as much as 53% more than the current price!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your XP research is our analysis highlighting 5 key rewards that could impact your investment decision.
• Our free XP research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate XP's overall financial health at a glance.

No Opportunity In XP?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

• AI is about to change healthcare. These 34 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Invest in the nuclear renaissance through our list of 89 elite nuclear energy infrastructure plays powering the global AI revolution.
• Uncover the next big thing with 30 elite penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com